VALUTAZIONE DELL'UTILITA DEL VIGABATRIN NEL TRATTAMENTO A LUNGO TERMINE DELL'EPILESSIA: ESPERIENZA DECENNALE DI IMPIEGO CLINICO

Translated title of the contribution: Usefulness of Vigabatrin in the long-term treatment of epilepsy: A 10-year clinical experience

A. Tartara, C. A. Galimberti, R. Manni, I. Sartori, G. Castelnovo, E. Perucca

Research output: Contribution to journalArticle

Abstract

Among 99 patients who received add-on GVG treatment for epilepsy uncontrolled by conventional treatment, 49 are still on the drug and maintain significant clinical improvement (41 patients) or complete seizure remission (8 patients, after a follow-up of 1 to 8 years). GVG was discontinued in 8 patients because of possibly drug-related adverse effects.

Translated title of the contributionUsefulness of Vigabatrin in the long-term treatment of epilepsy: A 10-year clinical experience
Original languageItalian
Pages (from-to)95-96
Number of pages2
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number86-87
Publication statusPublished - 1994

ASJC Scopus subject areas

  • Clinical Neurology

Fingerprint Dive into the research topics of 'Usefulness of Vigabatrin in the long-term treatment of epilepsy: A 10-year clinical experience'. Together they form a unique fingerprint.

  • Cite this